Priority Date: 30.05.12 (JP 20120123781)

TARGET-TISSUE-SPECIFIC ANTIGEN-BINDING MOLECULE

  • Application ID: EP13797450
  • Status: EXAMINATION IN PROGRESS

Attorney

Employment test 51 - 200 employees
Company dna vossius and partner
operating since 1961
Headquarter in Munich and 3 offices
active in Legal Services and IP-related Communication Service

Specialization

This patent has the IPC combination A61, C07, C12, and G01 is specialized in the combination A61, C07, C12, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Kilburn & Strode LLP, Vereenigde Octrooibureaux NV (V.O.) and 52 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 30.05.2012 - Priority Date (JP 20120123781)
  • 05.12.2013 - Publication A1 (WO2013180200)
  • 08.04.2015 - Publication A1 (EP2857420)